Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer

Recently, considerable attention in the field of cancer therapy has been focused on the mammalian rapamycin target (mTOR), inhibition of which could result in autophagic cell death (ACD). Though novel combination chemotherapy of autophagy inducers with chemotherapeutic agents is extensively investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Dong, Chen, Binlong, He, Bing, Liu, Haibin, Lin, Zhiqiang, Lin, Jialiang, Zhang, Xiaoyan, Sun, Ning, Zhao, Libo, Wang, Xiaoling, Zhang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804482/
https://www.ncbi.nlm.nih.gov/pubmed/31649854
http://dx.doi.org/10.1016/j.apsb.2019.03.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804482/
https://www.ncbi.nlm.nih.gov/pubmed/31649854
http://dx.doi.org/10.1016/j.apsb.2019.03.006

Ejemplares similares